0: Invasive Pulmonary Aspergillosis (IPA) is a severe disease that can develop in immunocompromised hosts, such as individuals with neutropenia, those treated for hematological malignancies, and recipients of hematopoietic stem cell (HSCT) or solid organ transplantation (SOT) [ 13].
1: Despite improvements in antifungal therapy and the availability of better diagnostic tools, the detection, definitive diagnosis, and treatment of this disease remains challenging.
